None of us should be that surprised the BLA is dead . 4 out of 5 BLAs get approved and ours didn’t when the fda rejected it . Add on top of that the data mess by the CRO and a lack of emphasis in the last cc were also a head’s up. Now this company can truly focus on NASH and cancer , put the BLA and Covid in the rear view mirror and finally provide some focus on what’s important and what we are leaving behind . The remnants of NPs reign are just about flushed out of the system and Cyrus can build this company in a way that will produce an approved drug